Bortemib 2 Injection
Marketer
Khandelwal Laboratories Pvt Ltd
Salt Composition
Bortezomib (2mg)
Overview Bortemib 2 Injection
Velcade (bortezomib) injection treats multiple myeloma and mantle cell lymphoma by inhibiting cancer cell proliferation. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your condition and may vary. Strict adherence to your doctor's instructions is crucial; incorrect usage or overdose can lead to severe adverse reactions. While benefits may not be immediate (taking several weeks or months), discontinue use only under medical guidance. Common side effects include fatigue, nausea, vomiting, and decreased appetite. Increased fluid intake is often recommended. Due to potential drowsiness and dizziness, avoid operating machinery or driving. The medication can reduce blood cell counts, raising infection risk; regular blood tests monitoring blood cell levels, along with heart, liver, and uric acid levels, are necessary. Prior to treatment, disclose any liver, kidney, heart disease, or bleeding disorders to your physician. Report any cognitive changes, such as memory loss or difficulty concentrating. Inform your healthcare provider of all other medications you are taking, as interactions are possible. This medication is contraindicated during pregnancy and breastfeeding; effective contraception is essential for both partners throughout treatment.
Primary Ingredients of Bortemib 2 Injection
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Bortemib 2 Injection
Myeloma and mantle cell lymphoma
Major Benefits of Bortemib 2 Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Bortemib 2 Injection:
- Low blood platelets
- Fatigue
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Psychiatric disturbances
- Nausea
- Vomiting
- Loss of appetite
- Fever
- Anemia (low number of red blood cells)
- Diarrhea
- Decreased appetite
- Decreased white blood cell count (neutrophils)
- Constipation
How to use Bortemib 2 Injection:
The medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Bortemib 2 Injection works:
Bortemib 2 Injection is a cancer therapeutic agent. Its mechanism of action involves inhibiting the cellular degradation of proteins. This protein accumulation within cancerous cells ultimately triggers their demise.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Bortemib 2 Injection and alcohol can lead to increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Administering Bortemib 2 Injection to pregnant individuals poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might deem its use justifiable if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Lactation is contraindicated during Bortemib 2 Injection therapy due to potential infant toxicity.
DrivingUNSAFE
Administering Bortemib 2 Injection may induce adverse reactions impacting driving capabilities. These reactions can include fatigue, vertigo, syncope, or visual impairment, potentially hindering safe operation of a vehicle.
KidneyCAUTION
Patients with significant kidney impairment should receive Bortemib 2 Injection with close monitoring. Dosage modification of Bortemib 2 Injection might be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should receive Bortemib 2 Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Bortemib 2 Injection :
Omit a Bortemib 2 Injection dose? Seek your physician's advice immediately.
Facts to Know About Bortemib 2 Injection
| Label | Value |
|---|---|
| Chemical Type | Phenylalanine-based Compounds |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
3,018 People bought this recently